The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia

<p>Myelodysplastic Syndromes (MDS) are a heterogeneous group of haematological malignancies characterised by ineffective haematopoiesis and dysplastic bone marrow changes. Patients frequently progress to Acute Myeloid Leukaemia and this is associated with very poor clinical outcomes. This t...

Mô tả đầy đủ

Chi tiết về thư mục
Tác giả chính:	Doolittle, H
Tác giả khác:	Jacobsen, S
Định dạng:	Luận văn
Được phát hành:	2017

Những quyển sách tương tự

Characterising early human lympho-myeloid haematopoietic progenitors and their relationship with acute myeloid leukaemia stem cells
Bằng: Aboukhalil, Z
Được phát hành: (2018)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
Bằng: Pimjai Niparuck, et al.
Được phát hành: (2021-10-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bằng: Ramy Rahmé, et al.
Được phát hành: (2023-04-01)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
Bằng: Daver, NG, et al.
Được phát hành: (2022)

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
Bằng: Yuxin Wang, et al.
Được phát hành: (2022-07-01)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
Bằng: Fidler, C, et al.
Được phát hành: (2004)

TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
Bằng: Ugo Testa, et al.
Được phát hành: (2023-06-01)

P1288: UNMANIPULATED PERIPHERAL HAPLOIDENTICAL HAEMATOPOIETIC STEM CELL TRANSPLANT IS AN EFFECTIVE CONSOLIDATIVE STRATEGY FOR HIGH-RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME
Bằng: Fabio Serpenti, et al.
Được phát hành: (2023-08-01)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
Bằng: Čolović Nataša, et al.
Được phát hành: (2023-01-01)

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
Bằng: Lijuan Zhang, et al.
Được phát hành: (2023-12-01)

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia
Bằng: Kathy L. McGraw, et al.
Được phát hành: (2016-08-01)

Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide
Bằng: Laurence Lodé, et al.
Được phát hành: (2018-04-01)

Identification and characterisation of the haematopoietic stem/progenitor cells at risk for leukaemia development following radiation exposure
Bằng: Verbiest, T
Được phát hành: (2016)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
Bằng: Y. Fang, et al.
Được phát hành: (2022-06-01)

Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations
Bằng: Laurence Lodé, et al.
Được phát hành: (2018-01-01)

Unravelling haematopoietic stem cell dysfunction in isolated Del(5q) myelodysplastic syndromes
Bằng: Stenson, L
Được phát hành: (2015)

Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
Bằng: Nabih Maslah, et al.
Được phát hành: (2020-06-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
Bằng: R Edlin, et al.
Được phát hành: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
Bằng: R Edlin, et al.
Được phát hành: (2010-05-01)

Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen
Bằng: Nikeeta Mandhan, et al.
Được phát hành: (2022-01-01)

Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
Bằng: Lu Bai, et al.
Được phát hành: (2022-08-01)

Allogeneic Haematopoietic Stem Cell Transplantation for Chronic Myeloid Leukaemia in the Era of Tyrosine Kinase Inhibitors
Bằng: Ahmet Emre Eskazan, et al.
Được phát hành: (2018-08-01)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
Bằng: Katharina T. Prochazka, et al.
Được phát hành: (2019-03-01)

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
Bằng: Marianna B. Ruzinova, et al.
Được phát hành: (2019-08-01)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
Bằng: Boultwood, J, et al.
Được phát hành: (2009)

Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia
Bằng: Sitânia Chiesa, et al.
Được phát hành: (2024-12-01)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
Bằng: Goh, Chermaine Yu Zhen
Được phát hành: (2021)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
Bằng: Campbell, L, et al.
Được phát hành: (2006)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
Bằng: Matteo Molica, et al.
Được phát hành: (2021-02-01)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
Bằng: Pierre Bories, et al.
Được phát hành: (2020-01-01)

Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
Bằng: Pierre Bories, et al.
Được phát hành: (2020-01-01)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Bằng: Haase, D, et al.
Được phát hành: (2019)

To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
Bằng: David A. Sallman
Được phát hành: (2020-06-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
Bằng: Shyam A. Patel, et al.
Được phát hành: (2023-11-01)

Acute Lymphoblastic Leukaemia in the Youngest: Haematopoietic Stem Cell Transplantation and Beyond
Bằng: Adriana Balduzzi, et al.
Được phát hành: (2022-02-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
Bằng: Boultwood, J, et al.
Được phát hành: (2004)

INVESTIGATION OF THE IMPACT OF THE R248Q MUTATION IN THE TP53 GENE ON THE INTERACTION OF THE P53 PROTEIN WITH THE DRUG APR-246 IN ACUTE MYELOID LEUKEMIA
Bằng: LMF Bertoline, et al.
Được phát hành: (2024-10-01)

Recruiting TP53 to target chronic myeloid leukemia stem cells
Bằng: Steven Grant
Được phát hành: (2020-05-01)

P471: POLO-LIKE KINASE 4 INHIBITION INDUCED ANTI-LEUKAEMIC EFFECTS THROUGH HISTONE MODIFICATION IN TP53 MUTATED ACUTE MYELOID LEUKAEMIA
Bằng: Wing Lam, et al.
Được phát hành: (2023-08-01)

What have we learned about TP53-mutated acute myeloid leukemia?
Bằng: Moazzam Shahzad, et al.
Được phát hành: (2024-11-01)